• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肺活量测定保存率受损相关的蛋白质。

Proteins associated with preserved ratio impaired spirometry.

作者信息

Lindberg Eva, Zhou Xingwu, Behndig Annelie F, Caidahl Kenneth, Egesten Arne, Engström Gunnar, Engvall Jan E, Eriksson Maria J, Fall Tove, Gummesson Anders, Hamrefors Viktor, Janson Christer, Johnsson Åse, Lindberg Anne, Mannila Maria, Nyström Fredrik H, Olin Anna-Carin, Sköld C Magnus, Söderberg Stefan, Tanash Hanan, Torén Kjell, Östgren Carl Johan, Malinovschi Andrei, Blomberg Anders

机构信息

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Department of Statistics, Uppsala University, Uppsala, Sweden.

出版信息

ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01045-2024. eCollection 2025 May.

DOI:10.1183/23120541.01045-2024
PMID:40589910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208607/
Abstract

BACKGROUND

Preserved ratio impaired spirometry (PRISm) is a spirometry pattern of interest regarding incident airflow obstruction and higher mortality risk. We applied a proteomic approach to gain more insight into the biological mechanisms associated with PRISm.

METHODS

From the population-based Swedish Cardiopulmonary Bioimage Study (SCAPIS), participants in the Main (n=4835) and Pilot (n=1054) studies, were included as discovery and replication cohorts. The lower limit of normal (LLN) of post-bronchodilator forced expiratory volume in 1 s (FEV), forced vital capacity (FVC) and FEV/FVC was defined as the fifth percentile in healthy, never-smoking SCAPIS participants. Participants were subdivided into five groups: reference: FEV/FVC≥LLN and FEV≥LLN and FVC≥LLN (n=4084)); mild chronic airflow limitation (CAL): FEV/FVC<LLN and FEV≥LLN (n=278); moderate-severe CAL: FEV/FVC<LLN and FEV<LLN (n=170); restrictive spirometric pattern (RSP): FEV/FVC ≥LLN and FVC<LLN (n=238); and PRISm: FEV/FVC≥LLN and FEV<LLN (n=238). Proximity extension assays were used to measure 168 proteins. The associations of each standardised protein were assessed with each study group by multiple linear regression models, adjusting for age, sex, body mass index (BMI), smoking, physical activity and study centres, and corrected for multiple testing to control for a false discovery rate of 5%.

RESULTS

Eight proteins were associated with PRISm and replicated: tumour necrosis factor receptor superfamily member 10A, interleukin-6, paraoxonase 3 (negative association), renin, urokinase plasminogen activator surface receptor (U-PAR), E-selectin, matrix metalloproteinase 7 and chitinase-3-like protein 1. Interleukin-6 and U-PAR were also associated with moderate-severe CAL and E-selectin with RSP. In addition, five other proteins were associated with moderate-severe CAL and three with RSP.

CONCLUSION

Protein profile in PRISm differs from other spirometric patterns suggesting specific disease mechanisms.

摘要

背景

肺功能测定中保存比率受损(PRISm)是一种与气流阻塞及较高死亡风险相关的肺功能测定模式。我们采用蛋白质组学方法以更深入了解与PRISm相关的生物学机制。

方法

基于人群的瑞典心肺生物影像研究(SCAPIS)中,主要研究(n = 4835)和试点研究(n = 1054)的参与者被纳入作为发现和验证队列。支气管扩张剂后1秒用力呼气量(FEV)、用力肺活量(FVC)和FEV/FVC的正常下限(LLN)被定义为健康、从不吸烟的SCAPIS参与者中的第五百分位数。参与者被分为五组:参照组:FEV/FVC≥LLN且FEV≥LLN且FVC≥LLN(n = 4084);轻度慢性气流受限(CAL):FEV/FVC<LLN且FEV≥LLN(n = 278);中重度CAL:FEV/FVC<LLN且FEV<LLN(n = 170);限制性肺功能模式(RSP):FEV/FVC≥LLN且FVC<LLN(n = 238);以及PRISm:FEV/FVC≥LLN且FEV<LLN(n = 238)。采用邻位延伸分析来检测168种蛋白质。通过多元线性回归模型评估每种标准化蛋白质与各研究组的关联,并对年龄、性别、体重指数(BMI)、吸烟、体力活动和研究中心进行校正,同时针对多重检验进行校正以控制5%的假发现率。

结果

8种蛋白质与PRISm相关且得到验证:肿瘤坏死因子受体超家族成员10A、白细胞介素-6、对氧磷酶3(负相关)、肾素、尿激酶型纤溶酶原激活物表面受体(U-PAR)、E-选择素、基质金属蛋白酶7和几丁质酶-3-样蛋白1。白细胞介素-6和U-PAR也与中重度CAL相关,E-选择素与RSP相关。此外,还有5种其他蛋白质与中重度CAL相关,3种与RSP相关。

结论

PRISm中的蛋白质谱不同于其他肺功能测定模式,提示存在特定的疾病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/cb488c31a330/01045-2024.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/004520e85da7/01045-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/5b6883cc82e5/01045-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/cb488c31a330/01045-2024.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/004520e85da7/01045-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/5b6883cc82e5/01045-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1842/12208607/cb488c31a330/01045-2024.03.jpg

相似文献

1
Proteins associated with preserved ratio impaired spirometry.与肺活量测定保存率受损相关的蛋白质。
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01045-2024. eCollection 2025 May.
2
Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.与比值正常的肺功能受损及限制性肺通气模式相关的危险因素、发病率和死亡率:比值正常的肺功能受损及限制性肺通气模式的临床意义
Chest. 2025 Feb;167(2):548-560. doi: 10.1016/j.chest.2024.08.026. Epub 2024 Aug 27.
3
Plasma Protein Biomarkers of Spirometry Measures of Impaired Lung Function.肺功能受损的肺活量测定指标的血浆蛋白生物标志物
Chest. 2025 Jun;167(6):1557-1577. doi: 10.1016/j.chest.2024.11.012. Epub 2024 Nov 22.
4
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
5
Perinatal risk factors and lung function at 8 years of age in extremely preterm infants: Insights from a new Japanese bronchopulmonary dysplasia classification.极早早产儿围产期危险因素与8岁时的肺功能:来自日本新支气管肺发育不良分类的见解
Pediatr Neonatol. 2025 Jun 20. doi: 10.1016/j.pedneo.2025.05.005.
6
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
7
General population-based lung function trajectories over the life course: an accelerated cohort study.基于一般人群的终生肺功能轨迹:一项加速队列研究。
Lancet Respir Med. 2025 Jul;13(7):611-622. doi: 10.1016/S2213-2600(25)00043-8. Epub 2025 May 15.
8
Short-acting inhaled bronchodilators for cystic fibrosis.短效吸入性支气管扩张剂在囊性纤维化中的应用。
Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2.
9
Diagnostic utility of spirometry for children with induced laryngeal obstruction or chronic non-specific cough.儿童喉内阻塞或慢性非特异性咳嗽的肺功能诊断价值。
Am J Otolaryngol. 2024 Jul-Aug;45(4):104316. doi: 10.1016/j.amjoto.2024.104316. Epub 2024 Apr 23.
10
Longitudinal association between hemoglobin and lung function with insights into the incidence of airflow obstruction: an observational study.血红蛋白与肺功能的纵向关联及对气流阻塞发生率的洞察:一项观察性研究
BMC Pulm Med. 2025 Jan 30;25(1):50. doi: 10.1186/s12890-025-03505-3.

本文引用的文献

1
Restrictive Spirometric Pattern and Preserved Ratio Impaired Spirometry in a Population Aged 50-64 Years.50-64 岁人群中存在限制性肺通气功能障碍和比预计值差的肺通气功能障碍的模式。
Ann Am Thorac Soc. 2024 Nov;21(11):1524-1532. doi: 10.1513/AnnalsATS.202403-242OC.
2
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis.肺量测定中比预计值受损与死亡率的关联:系统评价和荟萃分析。
Eur Respir Rev. 2023 Nov 1;32(170). doi: 10.1183/16000617.0135-2023. Print 2023 Dec 31.
3
Longitudinal Changes and Association of Respiratory Symptoms with Preserved Ratio Impaired Spirometry (PRISm): The Nagahama Study.
纵向变化以及呼吸症状与肺量计测定比值正常但存在气流受限(PRISm)的关联:长滨研究
Ann Am Thorac Soc. 2023 Nov;20(11):1578-1586. doi: 10.1513/AnnalsATS.202301-050OC.
4
Consequences of Using Post- or Prebronchodilator Reference Values in Interpreting Spirometry.在解读肺功能检查时使用支气管扩张剂后或支气管扩张剂前参考值的后果。
Am J Respir Crit Care Med. 2023 Aug 15;208(4):461-471. doi: 10.1164/rccm.202212-2341OC.
5
Cardiovascular disease-linked plasma proteins are mainly associated with lung volume.与心血管疾病相关的血浆蛋白主要与肺容积有关。
ERJ Open Res. 2023 Mar 27;9(2). doi: 10.1183/23120541.00321-2022. eCollection 2023 Mar.
6
Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular Outcomes: A Large Prospective Cohort Study.肺量计功能比值保留但肺功能受损与心血管结局的关系:一项大型前瞻性队列研究。
Chest. 2023 Mar;163(3):610-623. doi: 10.1016/j.chest.2022.11.003. Epub 2022 Nov 11.
7
Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.哮喘-慢阻肺重叠临床指标:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 12;17:2567-2575. doi: 10.2147/COPD.S374079. eCollection 2022.
8
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.肺和冠状动脉疾病中的常见生理和蛋白质组学生物标志物。
PLoS One. 2022 Mar 9;17(3):e0264376. doi: 10.1371/journal.pone.0264376. eCollection 2022.
9
Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging.肺活量比值降低型肺功能受损新潜在亚型的不同死亡风险及纵向转变轨迹:来自英国老龄化纵向研究的证据
Front Med (Lausanne). 2021 Nov 11;8:755855. doi: 10.3389/fmed.2021.755855. eCollection 2021.
10
Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities.肺纤维化中的肾素-血管紧张素-醛固酮系统:发病机制到治疗可能性。
Pharmacol Res. 2021 Dec;174:105924. doi: 10.1016/j.phrs.2021.105924. Epub 2021 Oct 2.